12 Hour Nasal Decongestant Spray Interactions
There are 51 drugs known to interact with 12 Hour Nasal Decongestant Spray (oxymetazoline nasal), along with 3 disease interactions. Of the total drug interactions, 6 are major, and45 are moderate.
- View all 51 medications that may interact with 12 Hour Nasal Decongestant Spray
- View 12 Hour Nasal Decongestant Spray disease interactions (3)
Most frequently checked interactions
View interaction reports for 12 Hour Nasal Decongestant Spray (oxymetazoline nasal) and the medicines listed below.
- Abilify (aripiprazole)
- acetaminophen
- albuterol
- Artificial Tears (ocular lubricant ophthalmic)
- azithromycin
- Benadryl (diphenhydramine)
- Celexa (citalopram)
- cephalexin
- clonazepam
- Cymbalta (duloxetine)
- dexamethasone
- dicyclomine
- doxycycline
- gabapentin
- hydrocodone
- ibuprofen
- Lyrica (pregabalin)
- melatonin
- meloxicam
- MiraLAX (polyethylene glycol 3350)
- Mucinex DM (dextromethorphan / guaifenesin)
- omeprazole
- ondansetron
- ProAir HFA (albuterol)
- Risperdal (risperidone)
- Topamax (topiramate)
- trazodone
- valacyclovir
- Ventolin HFA (albuterol)
- Zofran (ondansetron)
12 Hour Nasal Decongestant Spray disease interactions
There are 3 disease interactions with 12 Hour Nasal Decongestant Spray (oxymetazoline nasal) which include:
More about 12 Hour Nasal Decongestant Spray (oxymetazoline nasal)
- 12 Hour Nasal Decongestant Spray consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (3)
- Side effects
- Dosage information
- During pregnancy
- Drug class: nasal antihistamines and decongestants
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.